Process for preparing medicinal mycological preparations
OwnerJames A. Wieser, James Martin Bell +1inventors
InventorsJames A. Wieser, James Martin Bell, Richard L. Sarnat
Life of this patent
Estimating the term…
Abstract
The invention provides medicinal fungal preparations that have twenty or more times more medicinal potency than corresponding medicinal fungal preparations made by prevailing means in the prior art. In particular the invention provides nutrient-supplemented bioactive cell-ruptured cultures of medicinal fungi for which the post-rupture extraction medium is edible or potable, and has no significant side effects. The invention further provides methods to prepare them, and pharmacological preparations based on whole-culture biomass including the growth medium and metabolites.
Claims20
A process for preparing high-potency fungal medicinal materials comprising the steps of:
- a) growing organisms from a medicinal fungal species in a culture on a cell-based growth medium, wherein:
- i) the fungal species is a species that is edible when raw;
- and
- ii) the cell-based growth medium is edible;
- b) placing at least a portion from-the fungal organisms and at least a portion from the cell-based growth medium into an extraction medium;
- thereby forming a biomass processing medium, wherein the extraction medium is edible and or potable;
- and
- c) in the biomass processing medium, rupturing substantially all cells of the fungal organisms and the growth medium cells that had been placed therein, thereby forming a medicinal composition, wherein;
- i) the medicinal composition comprises each of the following:
- contents from the ruptured fungal organisms, contents from the medicinal composition, and the extraction medium;
- ii) the medicinal composition is edible and or potable;
- and
- iii) enzymes and other proteins from the fungal organisms of step (a) remain largely undenatured throughout each of steps (a), (b), and (c).
A pharmaceutical composition that is made by a process for preparing high-potency fungal medicinal materials;
- wherein the process comprises the steps of:
- a) growing organisms from a medicinal fungal species in a culture on a cell-based growth medium, wherein:
- i) the fungal species is a species that is edible when raw;
- and
- ii) the cell-based growth medium is edible;
- b) placing at least a portion from the fungal organisms and at least a portion from the cell-based growth medium into an extraction medium, thereby forming a biomass processing medium, wherein the extraction medium is edible and or potable;
- and
- c) in the biomass processing medium, rupturing substantially all cells of the fungal organisms and the growth medium cells that had been placed therein, thereby forming a medicinal composition, wherein:
- i) the medicinal composition comprises each of the following:
- contents from the ruptured fungal organisms, contents from the medicinal composition, and the extraction medium;
- ii) the medicinal composition is edible and or potable;
- and
- enzymes and other proteins from the fungal organisms of step (a) remain largely undenatured throughout each of steps (a), (b), and (c).
A method of treating a subject, comprising pharmaceutical composition to treat a neurological disorder or cancer, and wherein the pharmaceutical composition is made by a process for preparing high-potency fungal medicinal materials, wherein the process comprises the steps of:
- a) growing organisms from a medicinal fungal species in a culture on a cell-based growth medium, wherein:
- i) the fungal species is a species that is edible when raw;
- and
- ii) the cell-based growth medium is edible;
- b) placing at least a portion from-the fungal organisms and at least a portion from the cell-based growth medium into an extraction medium, thereby forming a biomass processing medium, wherein the extraction medium is edible and or potable;
- and
- c) in the biomass processing medium, rupturing substantially all cells of the fungal organisms and the growth medium cells that had been placed therein, thereby forming a medicinal composition, wherein;
- i) the medicinal composition comprises each of the following:
- contents from the ruptured fungal organisms, contents from the medicinal composition, and the extraction medium;
- and
- ii) the medicinal composition is edible and or potable;
- and
- enzymes and other proteins from the fungal organisms of step (a) remain largely undenatured throughout each of steps (a), (b), and (c).
Dependencies are inferred from the claim text.